AstraZeneca Rare Diseases

• Business
• Environment
• European Union
• Financial
• Government
• Healthcare
• Industrial
• Investment
• Management
• Netherlands
• News
• Pharma & Biotech
• Science
• Technology
• United Kingdom

EQT Life Sciences Portfolio Company Amolyt Pharma Acquired by Alexion, AstraZeneca Rare Diseases for $1.05 Billion

(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for…